Neoadjuvant TherapyCystectomyUrinary DiversionUrinary Bladder NeoplasmsChemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsUrinary Reservoirs, ContinentCarcinoma, Transitional CellTreatment OutcomeNeoplasm StagingBreast NeoplasmsCombined Modality TherapyDisease-Free SurvivalCisplatinPrognosisEsophagectomyDoxorubicinChemoradiotherapy, AdjuvantTaxoidsRadiotherapy, AdjuvantNeoplasm Recurrence, LocalSurvival RateFluorouracilMuscle NeoplasmsLymph Node ExcisionEpirubicinRetrospective StudiesFree RadicalsUreterostomySurvival AnalysisCyclophosphamideAntineoplastic AgentsRectal NeoplasmsLymphatic MetastasisEsophageal NeoplasmsAdenocarcinomaAnthracyclinesNeoplasm, ResidualReceptor, erbB-2Follow-Up StudiesPaclitaxelNeoplasm InvasivenessPelvisNomogramsKaplan-Meier EstimateChemoradiotherapyVinblastineDeoxycytidineTumor Markers, BiologicalUroplakin IIOperative TimeCarcinoma, Squamous CellOsteosarcomaProspective StudiesRoboticsCarcinomaReceptors, EstrogenOrgan Sparing TreatmentsCarcinoma, Ductal, BreastTime FactorsUrethral NeoplasmsUrinary BladderMethotrexateMultivariate AnalysisBiomarkers, PharmacologicalSarcomaPositron-Emission TomographyLaparoscopyBridged CompoundsAntibodies, Monoclonal, HumanizedFluorodeoxyglucose F18Predictive Value of TestsMastectomy, SegmentalOrganoplatinum CompoundsCarcinoma, LobularUrotheliumReceptors, ProgesteroneHydroxyl RadicalPyonephrosisPreoperative CareTomography, X-Ray ComputedUrologic Surgical ProceduresPancreatic NeoplasmsDrug Administration ScheduleMastectomyBone NeoplasmsProportional Hazards ModelsAxillaRadiopharmaceuticalsCarboplatinIfosfamideLymph NodesTumor BurdenUreterEsophagogastric JunctionCystoscopyMultimodal ImagingImmunohistochemistryAntineoplastic Agents, HormonalProstatectomy